Dai Cui

848 total citations
43 papers, 636 citations indexed

About

Dai Cui is a scholar working on Endocrinology, Diabetes and Metabolism, Electrical and Electronic Engineering and Molecular Biology. According to data from OpenAlex, Dai Cui has authored 43 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Electrical and Electronic Engineering and 10 papers in Molecular Biology. Recurrent topics in Dai Cui's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Semiconductor Quantum Structures and Devices (6 papers) and Thyroid Disorders and Treatments (6 papers). Dai Cui is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Semiconductor Quantum Structures and Devices (6 papers) and Thyroid Disorders and Treatments (6 papers). Dai Cui collaborates with scholars based in China, United States and France. Dai Cui's co-authors include Ling Lan, Lin Jiang, Xiaoyun Liu, Huanhuan Chen, Michael Derwahl, He Shi, Yifang Hu, Xuqin Zheng, Yong Luo and D. Pavlidis and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Dai Cui

40 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dai Cui China 18 271 189 107 100 68 43 636
Patricia A. Smanik United States 12 640 2.4× 437 2.3× 205 1.9× 130 1.3× 73 1.1× 16 1.2k
Shunhua Xing United States 7 516 1.9× 416 2.2× 207 1.9× 221 2.2× 59 0.9× 7 907
Diana Caragacianu United States 13 121 0.4× 292 1.5× 56 0.5× 168 1.7× 131 1.9× 20 754
Eric E. Niederkofler United States 19 106 0.4× 725 3.8× 79 0.7× 77 0.8× 45 0.7× 26 1.1k
L. Demers United States 12 162 0.6× 283 1.5× 208 1.9× 504 5.0× 132 1.9× 18 1.0k
Karolina Zielińska Poland 8 73 0.3× 144 0.8× 68 0.6× 65 0.7× 32 0.5× 14 358
Malik Bisserier United States 19 51 0.2× 657 3.5× 68 0.6× 98 1.0× 166 2.4× 48 1.2k
Agnieszka Piekiełko‐Witkowska Poland 20 158 0.6× 831 4.4× 69 0.6× 124 1.2× 380 5.6× 51 1.1k
Alexander Hermani Germany 8 197 0.7× 622 3.3× 135 1.3× 156 1.6× 193 2.8× 8 847
Naohide Sato Japan 11 170 0.6× 230 1.2× 146 1.4× 110 1.1× 95 1.4× 24 601

Countries citing papers authored by Dai Cui

Since Specialization
Citations

This map shows the geographic impact of Dai Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Cui more than expected).

Fields of papers citing papers by Dai Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Cui. The network helps show where Dai Cui may publish in the future.

Co-authorship network of co-authors of Dai Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Dai Cui. A scholar is included among the top collaborators of Dai Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dai Cui. Dai Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, He, et al.. (2024). Predictive Factors for the Efficacy of Radioactive Iodine Treatment of Graves’ Disease. International Journal of Endocrinology. 2024(1). 7535093–7535093. 1 indexed citations
2.
Shi, He, Yifang Hu, Xiaoyun Liu, et al.. (2020). Risk Factors for the Relapse of Graves’ Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis. Clinical Therapeutics. 42(4). 662–675.e4. 21 indexed citations
3.
Miao, Shumei, Dai Cui, Shan Lu, et al.. (2020). The analysis of differential diagnosis of benign and malignant thyroid nodules based on ultrasound reports. Gland Surgery. 9(3). 653–660. 15 indexed citations
4.
Hu, Yifang, Lijuan Zhang, Huanhuan Chen, et al.. (2019). Analysis of Regulatory T Cell Subsets and Their Expression of Helios and PD-1 in Patients with Hashimoto Thyroiditis. International Journal of Endocrinology. 2019. 1–11. 23 indexed citations
5.
Zhang, Lijuan, et al.. (2018). Association between serum 25-hydroxy vitamin D concentrations and diabetic kidney disease in type 2 diabetic patients. 26(5). 402–406. 1 indexed citations
6.
Chen, Huanhuan, Hao Zhang, Yin Liu, et al.. (2018). miR-146a rs2910164 Polymorphism and Risk of Papillary Thyroid Carcinoma: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 22(12). 674–679. 3 indexed citations
8.
Xu, Kuanfeng, et al.. (2016). Association between TSHR gene polymorphism and the risk of Graves' disease: a meta-analysis. Journal of Biomedical Research. 30(6). 466–466. 9 indexed citations
10.
Liu, Xiaoyun, Lijun Zhu, Zhixiao Wang, et al.. (2016). Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China. Scientific Reports. 6(1). 28414–28414. 16 indexed citations
11.
Xu, Bojin, Hui Yang, Huanhuan Chen, et al.. (2015). 2,3′,4,4′,5-Pentachlorobiphenyl Induces Inflammatory Responses in the Thyroid Through JNK and Aryl Hydrocarbon Receptor-Mediated Pathway. Toxicological Sciences. 149(2). 300–311. 25 indexed citations
12.
Liu, Xiaoyun, Lijun Zhu, Dai Cui, et al.. (2014). Annual Financial Impact of Thyroidectomies for Nodular Thyroid Disease in China. Asian Pacific Journal of Cancer Prevention. 15(14). 5921–5926. 8 indexed citations
13.
Xu, Kuanfeng, Xiaoyun Liu, Fan Yang, et al.. (2013). PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study. PLoS ONE. 8(11). e79150–e79150. 20 indexed citations
14.
Li, Wen, Hongwei Guo, Pei Cheng, et al.. (2013). Morphological and functional deterioration of the rat thyroid following chronic exposure to low-dose PCB118. Experimental and Toxicologic Pathology. 65(7-8). 989–994. 22 indexed citations
15.
Lan, Ling, Yong Luo, Dai Cui, et al.. (2013). Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. International Journal of Oncology. 43(1). 113–120. 62 indexed citations
16.
Cui, Dai, Yuanyuan Fu, Lingling Qian, et al.. (2011). UCP2 −866G/A and Ala55Val, and UCP3 −55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study. Diabetologia. 54(9). 2315–2324. 33 indexed citations
17.
Lan, Ling, Dai Cui, Yong Luo, et al.. (2010). [Beneficial effects of retinoic acid on in vitro invasiveness of human thyroid carcinoma cell lines].. PubMed. 90(34). 2407–11. 1 indexed citations
18.
Lan, Ling, Dai Cui, Yong Luo, et al.. (2009). Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro. Journal of Endocrinological Investigation. 32(9). 731–738. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026